Know a great AI tool or AI news source? Submit it to AiByts
fda4 min read

How FDA scientists opposed the Trump administration’s push for easier access to peptides

A plan to give Americans easier access to unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr. was opposed by most Food and Drug Administration scientific staff members, who had limited input in drafting the policy, according to six people familiar with the policy’s development.

By Associated PressFast Company AI
How FDA scientists opposed the Trump administration’s push for easier access to peptides

Read the full story

Originally published by Fast Company AI on Oct 28, 2026.

Read on Fast Company AI(opens in a new tab)

Comments

Sign in to join the discussion.

No comments yet — be the first to share your thoughts.